The HRA recently carried out a survey as part of our strategic objective to improve research transparency. The survey aimed to establish some of the current obstacles to transparency, and to identify future opportunities to improve practices.
Faster development of new treatments for diseases like cancer, heart disease and asthma are set to emerge following a £37.5 million investment in new Digital Innovation Hubs across the UK.
